Position in SANA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$951,108
+$777,183 QoQ
Shares Held
272,524
+351.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Derivatives in SANA
reported options exposure · as of Sep 30, 2024CallValue
$61,152
CallShares
14,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. SANA ranks #147 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in SANA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $951,108 | 272,524 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $173,925 | 60,391 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $629,888 | 154,764 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $300,744 | 84,717 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $441,060 | 161,561 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $528,475 | 314,569 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $436,040 | 267,510 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $61,152 | 14,700 | Call | Defined | 2024-11-12 | |
| 2024-09-30 | $437,402 | 105,145 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,940,089 | 355,328 | Shares | Defined | 2024-08-12 | |
| 2024-06-30 | $81,354 | 14,900 | Call | Defined | 2024-08-12 | |
| 2024-03-31 | $4,696,700 | 469,670 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $774,791 | 189,900 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $562,580 | 145,370 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $785,252 | 131,754 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,107,777 | 338,770 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $946,100 | 239,519 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $2,428,740 | 404,790 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,535,027 | 394,250 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $790,828 | 95,742 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,960,751 | 191,263 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,229,051 | 54,576 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,953,049 | 150,206 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $79,357 | 2,371 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||